EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Randomisierte kontrollierte StudieOpen Access

The effects of sodium reduction and the DASH diet on ambulatory blood pressure: overall and race-stratified results from the DASH-Sodium trial

Tasfia Hussain iD, Stephen P Juraschek iD, Edgar R Miller, Frank M Sacks, Paul R Conlin, Laura Svetkey, Thomas Moore, Lawrence J Appel iD

American Journal of Hypertension · 2026

DOI: 10.1093/ajh/hpag079 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift American Journal of Hypertension, 2026. Verfasst von Tasfia Hussain und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States. Hauptthemen laut MEDLINE: Black or African American, Blood Pressure, Diet, Sodium-Restricted, Dietary Approaches To Stop Hypertension. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK, NHLBI NIH HHS, NCRR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

On average, Black adults compared to White adults have higher ambulatory blood pressure (ABP), particularly during sleep.

Methods

Participants were randomly assigned to eat a control diet or the DASH diet (n = 335 with ABP, 58% self-reported Black). On their assigned diet, participants had 3, randomly ordered, 30-day feeding periods with different sodium levels (low, intermediate, and high). ABP was obtained at the end of each period.

Results

Compared to the control diet with high sodium (reference), reducing sodium and consuming the DASH diet, alone or combined, significantly lowered 24-hour, awake, and asleep systolic and diastolic ABP in Black and Non-Black participants. The DASH diet with low sodium reduced mean (95%CI) awake SBP by 9.0 mmHg (6.4, 11.7) in Black participants and 7.5 mmHg (4.5, 10.6) in Non-Black participants, and mean asleep SBP by 8.0 mmHg (4.8, 11.2) in Black participants and 7.4 mmHg (3.9,11.0) in Non-Black participants in comparison to the reference (each P < .05). Despite reductions in asleep ABP from the DASH diet and sodium reduction, significant differences by race persisted in achieved ABP, consistently so for asleep ABP. Mean ± SE achieved levels of asleep SBP on the control diet with high sodium were 124.1 ± 0.6 mmHg in Black participants and 120.2 ± 0.7 mmHg in Non-Black participants (P < .005), while on the DASH diet with low sodium, achieved levels were 115.2 ± 0.5 mmHg in Black participants and 112.5 ± 0.7 mmHg in Non-Black participants (P < .005).

Conclusions

Despite clinically relevant reductions in ABP from sodium reduction and the DASH diet in both Black and Non-Black participants, racial differences in achieved levels of asleep ABP persisted. Clinical Trial Registration Trial Number NCT00000608.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Black or African AmericanBlood PressureDiet, Sodium-RestrictedDietary Approaches To Stop HypertensionHypertensionSodium, DietaryAdultFemaleHumansMaleMiddle AgedBlood Pressure Monitoring, AmbulatoryRacial GroupsTime FactorsTreatment Effect HeterogeneityTreatment OutcomeWhite

Stichwörter der Autor:innen

DASHblood pressurehypertensionnutritionsodium

Substanzen

Sodium, Dietary

Autor:innen und Institutionen

  • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
  • Emory University School of Medicine, Atlanta, GA, United States.
  • Division of General Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
  • Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, MD, United States.
  • Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Department of Medicine, Harvard Medical School, Boston, MA, United States.

ORCID-Profile: Tasfia Hussain, Stephen P Juraschek, Lawrence J Appel

Förderung

  • NIDDK
  • NHLBI NIH HHS
  • NCRR NIH HHS

Zitieren

APA

Hussain, T., Juraschek, S. P., Miller, E. R., Sacks, F. M., Conlin, P. R., Svetkey, L., Moore, T., & Appel, L. J. (2026). The effects of sodium reduction and the DASH diet on ambulatory blood pressure: overall and race-stratified results from the DASH-Sodium trial. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpag079

Vancouver

Hussain T, Juraschek SP, Miller ER, Sacks FM, Conlin PR, Svetkey L, et al. The effects of sodium reduction and the DASH diet on ambulatory blood pressure: overall and race-stratified results from the DASH-Sodium trial. American Journal of Hypertension. 2026. doi:10.1093/ajh/hpag079

BibTeX
@article{Hussain2026,
  author = {Hussain, Tasfia and Juraschek, Stephen P and Miller, Edgar R and Sacks, Frank M and Conlin, Paul R and Svetkey, Laura and Moore, Thomas and Appel, Lawrence J},
  title = {The effects of sodium reduction and the DASH diet on ambulatory blood pressure: overall and race-stratified results from the DASH-Sodium trial},
  journal = {American Journal of Hypertension},
  year = {2026},
  doi = {10.1093/ajh/hpag079}
}
Kostenlos starten →